Edge AI Demand Fuels 90% Sales Surge at Ambiq Micro; Q3 Guidance Tops Street
AMBQ has more than doubled off its 52-week low of $22.12.
Summary
Ambiq Micro posted Q2 2026 net sales of $33.9M, up ~90% YoY, and guided Q3 sales to $36.0M–$37.0M, reflecting strong edge AI momentum. Gross margins expanded, losses narrowed, and the company holds $366.8M in cash.
Key Events · Earnings and Guidance · AMBQ
-
Record Q2 Sales, Up ~90% YoY
Driven by accelerating edge AI demand across customers and products, net sales reached $33.9 million in Q2 2026, marking the fifth consecutive quarter of growth.
-
Gross Margin Expansion
Non-GAAP gross margin expanded 450 basis points year-over-year to 47.2%, as non-GAAP gross profit surged 109% to $16.0 million, reflecting favorable mix and manufacturing efficiencies.
-
Q3 Guidance Above Consensus
The company guided Q3 net sales to $36.0–$37.0 million, non-GAAP gross margin to 46.5%–47.5%, and non-GAAP net loss per share to ($0.20)–($0.12), implying continued sequential improvement.
-
Strong Balance Sheet with $366.8M Cash
Cash and equivalents stood at $366.8 million as of June 30, 2026, following an upsized public offering in June that raised approximately $168 million in net proceeds.
Analysis · AMBQ · Manufacturing
Accelerating edge AI demand propelled Ambiq Micro to record quarterly net sales of $33.9 million, a roughly 90% year-over-year leap. Gross profit more than doubled, and non-GAAP gross margin widened by 450 basis points to 47.2%. Looking ahead, the company guided for Q3 net sales of $36.0–$37.0 million—a sixth straight quarter of sequential growth—with non-GAAP net loss per share narrowing to ($0.20)–($0.12). A June upsized offering fortified the balance sheet with $366.8 million in cash, providing ample runway to invest in capacity expansion amid industry-wide supply constraints. The dual listing on the Singapore Exchange broadens investor access and underscores global growth ambitions.
At the time of this filing, AMBQ was trading at $68.91 on NYSE in the Manufacturing sector, with a market capitalization of approximately $1.5B. The 52-week trading range was $22.12 to $91.61. This filing was assessed with positive market sentiment and an importance score of 7 out of 10.